Physician profile
Andrew J Wright
NPI 1154550168
$7,271.55
in general payments reported to CMS, 2019-2025
33 companies · $660 in 2025
The $660 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,266 · 2020: $402 · 2021: $590 · 2022: $2,078 · 2023: $540 · 2024: $1,736 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,392 · Travel and Lodging: $531 · Education: $13.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,391.54 |
| Travel and Lodging | $530.56 |
| Education | $13.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,685.46 | 2021-2025 | Urolift, Barrigel |
| Neotract INC. | $1,235.66 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $524.47 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $381.05 | 2020-2025 | Moses 550 Dfl, Lithovue Elite, Moses |
| Myovant Sciences INC. | $332.94 | 2021-2022 | |
| 180 Medical, INC. | $236.20 | 2020-2025 | Gentlecath Glide, Gentlecath |
| Pfizer INC. | $202.69 | 2019-2025 | |
| Amgen INC. | $169.67 | 2019-2020 | |
| Janssen Biotech, INC. | $155.35 | 2019-2025 | Erleada, Akeega |
| Procept Biorobotics Corporation | $151.12 | 2022 | |
| Astellas Pharma US INC | $137.47 | 2019-2023 | Myrbetriq, Xtandi |
| Laborie Medical Technologies Corp. | $96.67 | 2023 | |
| Abbvie INC. | $95.05 | 2021-2025 | |
| Urogen Pharma, INC. | $94.73 | 2023-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $87.90 | 2019-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $85.84 | 2019-2025 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $84.64 | 2022 | |
| Tolmar, INC. | $75.87 | 2023-2024 | |
| Coloplast Corp | $71.91 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $60.80 | 2024 | Lynparza |
| Sun Pharmaceutical Industries INC. | $56.44 | 2023-2024 | Yonsa |
| Progenics Pharmaceuticals, INC. | $49.88 | 2023-2024 | Pylarify |
| Dendreon Pharmaceuticals LLC | $28.49 | 2019-2022 | |
| Organogenesis INC. | $25.67 | 2023 | Puraply |
| Angiodynamics, INC. | $21.65 | 2024 | Nanoknife |
| Blue Earth Diagnostics | $19.46 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $18.18 | 2022 | |
| Cook Medical LLC | $17.56 | 2025 | Cook |
| Smith+Nephew, INC. | $15.05 | 2023 | Stravix |
| Verity Pharmaceuticals INC. | $14.83 | 2023 | Trelstar |
| Mission Pharmacal Company | $13.17 | 2022 | |
| Merck Sharp & Dohme LLC | $13.04 | 2021 | |
| Acerus Pharmaceuticals Corporation | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.